Induction of small cell lung cancer by somatic inactivation of both Trp53 and Rb1 in a conditional mouse model.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Cancer Cell

• Publication date

  2003-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S1535-6108(03)00220-4PMID 14522252
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• p63 and TTF-1 immunostaining. A useful marker panel for distinguishing small cell carcinoma of lung from poorly differentiated squamous cell carcinoma of lung.

  2003cited by this paper
• Hedgehog signalling within airway epithelial progenitors and in small-cell lung cancer

  2003cited by this paper
• Chemotherapy for small cell lung cancer.

  2003cited by this paper
• Neuroblastoma: biological insights into a clinical enigma

  2003cited by this paper
• Molecular genetics of lung cancer.

  2003cited by this paper
• Molecular and cellular biology of small cell lung cancer.

  2003cited by this paper
• Lung cancer in Europe in 2000: epidemiology, prevention, and early detection.

  2003cited by this paper
• The retinoblastoma tumour suppressor in development and cancer

  2002cited by this paper
• Focus on lung cancer.

  2002cited by this paper
• Modulation of Basic Helix-Loop-Helix Transcription Complex Formation by Id Proteins during Neuronal Differentiation*

  2002cited by this paper
• The RB and p53 pathways in cancer.

  2002cited by this paper
• Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras.

  2001cited by this paper
• Synergistic tumor suppressor activity of BRCA2 and p53 in a conditional mouse model for breast cancer

  2001cited by this paper
• Molecular genetics of small cell lung carcinoma.

  2001cited by this paper
• Diversity of gene expression in adenocarcinoma of the lung

  2001cited by this paper
• Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses

  2001cited by this paper
• Complementary roles of pro-gastrin-releasing peptide (ProGRP) and neuron specific enolase (NSE) in diagnosis and prognosis of small-cell lung cancer (SCLC).

  2001cited by this paper
• N-CAM modulates tumour-cell adhesion to matrix by inducing FGF-receptor signalling

  2001cited by this paper
• The developmental biology of brain tumors.

  2001cited by this paper
• Mouse model for lung tumorigenesis through Cre/lox controlled sporadic activation of the K-Ras oncogene

  2001cited by this paper
• Evidence That Helix-Loop-Helix Proteins Collaborate with Retinoblastoma Tumor Suppressor Protein to Regulate Cortical Neurogenesis

  2000cited by this paper
• Pathology of small-cell lung cancer

  2000cited by this paper
• Neuroepithelial bodies of pulmonary airways serve as a reservoir of progenitor cells capable of epithelial regeneration.

  2000cited by this paper
• Targeted disruption of the three Rb-related genes leads to loss of G(1) control and immortalization.

  2000cited by this paper
• Id2 is a retinoblastoma protein target and mediates signalling by Myc oncoproteins

  2000cited by this paper
• Ablation of the retinoblastoma gene family deregulates G(1) control causing immortalization and increased cell turnover under growth-restricting conditions.

  2000cited by this paper
• Induction of medulloblastomas in p53-null mutant mice by somatic inactivation of Rb in the external granular layer cells of the cerebellum.

  2000cited by this paper
• Basic helix-loop-helix transcription factors regulate the neuroendocrine differentiation of fetal mouse pulmonary epithelium.

  2000cited by this paper
• Constitutive achaete-scute homologue-1 promotes airway dysplasia and lung neuroendocrine tumors in transgenic mice.

  2000cited by this paper
• Molecular and genetic aspects of lung cancer.

  2000cited by this paper
• Conditional clara cell ablation reveals a self-renewing progenitor function of pulmonary neuroendocrine cells.

  2000cited by this paper
• Value of Thyroid Transcription Factor-1 Immunostaining in Distinguishing Small Cell Lung Carcinomas From Other Small Cell Carcinomas

  2000cited by this paper
• The significance of NSE and CEA as a differentiation marker for the cellular heterogeneity of small cell lung cancer.

  1999cited by this paper
• The retinoblastoma gene family in differentiation and development

  1999cited by this paper
• Calcitonin driven v-Ha-ras induces multilineage pulmonary epithelial hyperplasias and neoplasms

  1999cited by this paper
• The biological characteristics of chromogranin A and its role as a circulating marker in neuroendocrine tumours.

  1999cited by this paper
• Flp-mediated tissue-specific inactivation of the retinoblastoma tumor suppressor gene in the mouse

  1998cited by this paper
• Mechanism of retinoblastoma gene inactivation in the spectrum of neuroendocrine lung tumors.

  1998cited by this paper
• An achaete-scute homologue essential for neuroendocrine differentiation in the lung

  1997cited by this paper
• Cyclin-dependent kinase inhibitor expression in pulmonary Clara cells transformed with SV40 large T antigen in transgenic mice.

  1997cited by this paper
• Embryonic mouse lung epithelial progenitor cells co-express immunohistochemical markers of diverse mature cell lineages.

  1996cited by this paper
• The p53-deficient mouse: a model for basic and applied cancer studies.

  1996cited by this paper
• Cooperative tumorigenic effects of germline mutations in Rb and p53

  1994cited by this paper
• Developmental rescue of an embryonic‐lethal mutation in the retinoblastoma gene in chimeric mice.

  1994cited by this paper
• Identification of a human achaete-scute homolog highly expressed in neuroendocrine tumors.

  1993cited by this paper
• Effects of an Rb mutation in the mouse

  1992cited by this paper
• Simplified mammalian DNA isolation procedure.

  1991cited by this paper
• Molecular genetics of lung cancer.

  1988cited by this paper

• Stem cell control and cancer initiation by an autocrine, injury-activated Igf complex

  2026cites this paper
• PRC2 loss impairs small cell lung cancer tumorigenesis and enhances sensitivity to G9a/GLP inhibition.

  2026cites this paper
• Case report: A patient with EGFR L861Q positive adenosquamous lung carcinoma transforming into large cell neuroendocrine cancer after treatment with Almonertinib

  2025cites this paper
• ERBB2 signaling drives immune cell evasion and resistance against immunotherapy in small cell lung cancer

  2025influential citation
• Molecular Landscape and Therapeutic Strategies of Lung Cancer Lineage Plasticity.

  2025cites this paper
• RNF20 links the DNA damage response and metabolic rewiring in lung cancer through HIF1α

  2025cites this paper
• Genomic Profiling of Extensive Stage Small-Cell Lung Cancer Patients Identifies Molecular Factors Associated with Survival

  2025cites this paper
• Polo-like Kinase 1 Inhibitors Demonstrate In Vitro and In Vivo Efficacy in Preclinical Models of Small Cell Lung Cancer

  2025cites this paper
• Current and future therapies for small cell lung carcinoma

  2025cites this paper
• Lack of caspase 8 directs neuronal progenitor-like reprogramming and small cell lung cancer progression

  2025cites this paper
• Molecular subtyping dictates therapeutic response to anti-PD-L1 immunotherapy in ES-SCLC

  2025cites this paper
• Age distinguishes selection from causation in cancer genomes

  2025cites this paper
• Performance of Immunohistochemistry to Detect Rb/p53 Alterations in High-Grade Neuroendocrine Neoplasms: Staining Patterns and Comparison with Genetic Testing

  2025cites this paper
• An Autochthonous Model of Lung Cancer Identifies Requirements for Cellular Transformation in the Naked Mole-Rat.

  2025cites this paper
• RB1 inactivation in cutaneous carcinomas

  2025cites this paper
• Molecular Subtypes and Targeted Therapeutic Strategies in Small Cell Lung Cancer: Advances, Challenges, and Future Perspectives

  2025cites this paper
• Advancing small cell lung cancer metastasis research: innovations in preclinical mouse models

  2025influential citation
• Noninvasive molecular imaging using anti-Trop-2 aptamer for targeted therapy of small cell lung cancer

  2025cites this paper
• Challenges of small cell lung cancer heterogeneity and phenotypic plasticity

  2025influential citation
• The evolving landscape of brain metastasis: volume II.

  2025cites this paper
• EGFR-mutant lung adenocarcinoma transformed into small cell Lung cancer: A case report and literatures review

  2025cites this paper
• SMARCA4 is essential for early-stage tumor development but its loss promotes late-stage cancer progression in small-cell lung cancer

  2025cites this paper
• Neuroendocrine Transformation as a Mechanism of Resistance to Targeted Lung Cancer Therapies: Emerging Mechanisms and Their Therapeutic Implications

  2025cites this paper
• Primary de novo Epidermal Growth Factor Receptor Mutant Small Cell Lung Carcinomas: Clinicopathological Study of a Rare Entity Presenting in Treatment-Naïve Setting with Review of Literature

  2025influential citation
• Myc family proteins: Molecular drivers of tumorigenesis and resistance in neuroendocrine tumors.

  2025cites this paper
• Reversible therapeutic resistance in EGFR mutant lung cancer caused by RB1 loss induced lineage plasticity

  2025cites this paper
• Intratumoral heterogeneity and potential treatment strategies in small cell lung cancer

  2025influential citation
• Baseline retinoblastoma transcriptional corepressor 1 (Rb1) functional inactivation is a pre-requisite but not sufficient for small-cell histological transformation in epidermal growth factor receptor (EGFR) mutant lung adenocarcinomas post-tyrosine kinase inhibitor therapy

  2025cites this paper
• Autophagic flux modulates tumor heterogeneity and lineage plasticity in SCLC

  2025cites this paper
• Intracranial metastases from solid tumors: Call to Action and Consensus from the Society for Neuro-Oncology and American Society of Clinical Oncology Collaborative.

  2025cites this paper
• PDLIM2 in Lung Adenocarcinoma Metastasis

  2025cites this paper
• Multidisciplinary assessment of patients with extensive stage small cell lung cancer: A geriatric tumor board

  2025cites this paper
• Recent Advances in the Clinical Translation of Small-Cell Lung Cancer Therapeutics

  2025cites this paper
• Candidate Biomarker of Response to Immunotherapy In Small Cell Lung Cancer

  2025cites this paper
• Functional synapses between neurons and small cell lung cancer

  2025cites this paper
• Small Cell Lung Cancer: A Review.

  2025cites this paper
• SMARCA4 loss promotes late-stage tumor progression in non-neuroendocrine small-cell lung cancer.

  2025cites this paper
• Dopamine D2 receptor agonists abrogate neuroendocrine tumour angiogenesis to inhibit chemotherapy-refractory small cell lung cancer progression

  2024cites this paper
• Genetic and epigenetic features of neuroendocrine prostate cancer and their emerging applications.

  2024cites this paper
• A novel mouse model recapitulating the MMR-defective SCLC subtype uncovers an actionable sensitivity to immune checkpoint blockade

  2024influential citation
• Sympathetic Neurons Promote Small Cell Lung Cancer Through the Beta-2 Adrenergic Receptor.

  2024cites this paper
• Role of CDK4/6 inhibitors in targeting Rb proficient small cell lung cancer

  2024cites this paper
• Metastatic organotropism in small cell lung cancer

  2024cites this paper
• Strategies to Target Chemoradiotherapy Resistance in Small Cell Lung Cancer

  2024cites this paper
• Stimulation of cGAS-STING pathway as a challenge in the treatment of small cell lung cancer: a feasible strategy?

  2024cites this paper
• Coexistence of DIPNECH with pulmonary adenocarcinoma: Coincidence or by design?

  2024cites this paper
• Small cell lung cancer: emerging subtypes, signaling pathways, and therapeutic vulnerabilities

  2024influential citation
• Small cell lung cancer profiling: an updated synthesis of subtypes, vulnerabilities, and plasticity.

  2024cites this paper
• Genetic tracing uncovers the importance of epithelial-to-mesenchymal transition in small cell lung cancer chemotherapy resistance but not metastasis

  2024cites this paper
• CDK9 inhibition as an effective therapy for small cell lung cancer

  2024cites this paper
• Blocking the angiopoietin-2–dependent integrin β-1 signaling axis abrogates small cell lung cancer invasion and metastasis

  2024cites this paper
• Distinct Regulation of ASCL1 by the Cell Cycle and Chemotherapy in Small Cell Lung Cancer

  2024cites this paper
• Evaluating RB1 and p53 as diagnostic markers in treatment‐related neuroendocrine prostate cancer through immunohistochemistry and genomic analysis of RB1 and TP53

  2024cites this paper
• 小细胞肺癌分子分型：向临床实践转化的挑战

  2024cites this paper
• Emerging advances in defining the molecular and therapeutic landscape of small-cell lung cancer

  2024cites this paper
• Mouse models for cancer research - current state and the perspective.

  2024cites this paper
• EHMT2-mediated transcriptional reprogramming drives neuroendocrine transformation in non–small cell lung cancer

  2024cites this paper
• Tissue-Based Diagnostic Biomarkers of Aggressive Variant Prostate Cancer: A Narrative Review

  2024cites this paper
• P53 and Rb Aberrations in Small Cell Lung Cancer (SCLC): From Molecular Mechanisms to Therapeutic Modulation

  2024cites this paper
• Novel insights into RB1 in prostate cancer lineage plasticity and drug resistance

  2024cites this paper
• Small cells – big issues: biological implications and preclinical advancements in small cell lung cancer

  2024cites this paper
• Genetically-engineered mouse models of small cell lung cancer: the next generation

  2024cites this paper
• COX6C expression driven by copy amplification of 8q22.2 regulates cell proliferation via mediation of mitosis by ROS-AMPK signaling in lung adenocarcinoma

  2024cites this paper
• Promises of Protein Kinase Inhibitors in Recalcitrant Small-Cell Lung Cancer: Recent Scenario and Future Possibilities

  2024cites this paper
• Genomic predictors of radiation response: recent progress towards personalized radiotherapy for brain metastases

  2024cites this paper
• Basal cell of origin resolves neuroendocrine–tuft lineage plasticity in cancer

  2024cites this paper
• Breathing new insights into the role of mutant p53 in lung cancer

  2024cites this paper
• Nuclear Factor I/B: Duality in Action in Cancer Pathophysiology.

  2024cites this paper
• A SWI/SNF-dependent transcriptional regulation mediated by POU2AF2/C11orf53 at enhancer

  2024cites this paper
• Monitoring the Cell Cycle of Tumor Cells in Mouse Models of Human Cancer.

  2023cites this paper
• Small Cell Lung Carcinoma: Current Diagnosis, Biomarkers, and Treatment Options with Future Perspectives

  2023cites this paper
• Neuroendocrine lineage commitment of small cell lung cancers can be leveraged into p53-independent non-cytotoxic therapy

  2023cites this paper
• Advancing immunotherapy in small cell lung cancer

  2023cites this paper
• Current Knowledge of Small Cell Lung Cancer Transformation from Non-Small Cell Lung Cancer.

  2023cites this paper
• Clinical insights into small cell lung cancer: Tumor heterogeneity, diagnosis, therapy, and future directions

  2023cites this paper
• Cellular Origins and Lineage Plasticity in Cancer.

  2023cites this paper
• p53 restoration in small cell lung cancer identifies a latent cyclophilin-dependent necrosis mechanism

  2023cites this paper
• On Target: An Intrapulmonary Transplantation Method for Modelling Lung Tumor Development in its Native Microenvironment.

  2023cites this paper
• Dissecting metastasis using preclinical models and methods

  2023cites this paper
• Significance of RB Loss in Unlocking Phenotypic Plasticity in Advanced Cancers.

  2023cites this paper
• From Chaos to Opportunity: Decoding Cancer Heterogeneity for Enhanced Treatment Strategies

  2023cites this paper
• Understanding SCLC heterogeneity and plasticity in cancer metastasis and chemotherapy resistance

  2023cites this paper
• Atrx deletion impairs CGAS/STING signaling and increases sarcoma response to radiation and oncolytic herpesvirus

  2023cites this paper
• Functional synapses between small cell lung cancer and glutamatergic neurons

  2023cites this paper
• Footprints: Stamping hallmarks of lung cancer with patient-derived models, from molecular mechanisms to clinical translation

  2023cites this paper
• Experimental mouse models for translational human cancer research

  2023cites this paper
• Molecular heterogeneity of small cell lung cancer and new therapeutic possibilities: a narrative review of the literature

  2023cites this paper
• Tumor grade-associated genomic mutations in Chinese patients with non-small cell lung cancer

  2023influential citation
• USP13 drives lung squamous cell carcinoma by switching lung club cell lineage plasticity

  2023cites this paper
• Small cell lung cancer plasticity enables NFIB-independent metastasis.

  2023cites this paper
• Experimental models for cancer brain metastasis

  2023cites this paper
• Crosstalk between small-cell lung cancer cells and astrocytes mimics brain development to promote brain metastasis

  2023cites this paper
• Progress in the knowledge on the transformation of lung adenocarcinoma to small-cell lung cancer

  2023cites this paper
• A Review on Small-Cell Lung Cancer: Epidemiology, Pathophysiology, Risk Factors, Diagnosis, Clinical Management and Treatment Modalities

  2023cites this paper
• An autochthonous model of lung cancer in the Naked Mole-Rat (Heterocephalus glaber)

  2023cites this paper
• Preclinical Modeling of Pathway-Targeted Therapy of Human Lung Cancer in the Mouse.

  2023cites this paper
• The emerging role of the gut microbiome in cancer cell plasticity and therapeutic resistance

  2023cites this paper
• AKT phosphorylation as a predictive biomarker for PI3K/mTOR dual inhibition-induced proteolytic cleavage of mTOR companion proteins in small cell lung cancer

  2022cites this paper
• Novel therapeutic combinations with PARP inhibitors for small cell lung cancer: A bench-to-bedside review.

  2022cites this paper
• NEMO- and RelA-dependent NF-κB signaling promotes small cell lung cancer

  2022cites this paper